NEU neuren pharmaceuticals limited

Ann: Trofinetide marketing application submitted in Europe, page-16

  1. 2,800 Posts.
    lightbulb Created with Sketch. 538
    Jon not coming to or not communicating on FFS requirements to start phase III is probably the catalyst. Share price has deteriorated since then.

    Hard to pick good entry points in such companies.
    Patience and trust in the company is definitely needed
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.